DR RAJU AND PARTNERS — All Prescriptions & Medications — Page 3
Practice Code: M83100 | STOKE-ON-TRENT, ST3 6AB
Showing results 101-150 of 490
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Spironolactone | 234 | 6,902 | £962 | -56.6% ▼ |
| Flucloxacillin sodium | 234 | 9,808 | £519 | -48.0% ▼ |
| Latanoprost | 234 | 2,090 | £1.1K | -51.8% ▼ |
| Senna | 233 | 13.2K | £288 | -61.3% ▼ |
| Betamethasone valerate | 227 | 17.1K | £1.2K | -41.0% ▼ |
| Sacubitril/valsartan | 224 | 11.3K | £18.5K | -6.5% ▼ |
| Rosuvastatin calcium | 221 | 9,072 | £243 | -75.4% ▼ |
| Empagliflozin | 218 | 6,356 | £7.9K | -65.2% ▼ |
| Perindopril erbumine | 214 | 10.5K | £910 | -59.7% ▼ |
| Warfarin sodium | 212 | 11.8K | £3.3K | -55.0% ▼ |
| Clarithromycin | 212 | 4,644 | £1.0K | -13.6% ▼ |
| Risperidone | 211 | 5,012 | £312 | -16.6% ▼ |
| Topiramate | 211 | 11.5K | £599 | +18.7% ▲ |
| Tiotropium bromide | 210 | 3,935 | £5.4K | -30.9% ▼ |
| Insulin aspart | 207 | 1,181 | £6.8K | -45.6% ▼ |
| Mebeverine hydrochloride | 204 | 14.5K | £447 | -34.3% ▼ |
| 204 | 2,190 | £530 | -2.4% ▼ | |
| Famotidine | 200 | 5,780 | £3.5K | -59.0% ▼ |
| Baclofen | 200 | 22.4K | £541 | -0.2% vs avg |
| Paroxetine hydrochloride | 199 | 7,578 | £274 | +6.6% ▲ |
| 198 | 102.8K | £1.1K | -79.9% ▼ | |
| Prochlorperazine maleate | 197 | 8,679 | £565 | -2.5% ▼ |
| Memantine hydrochloride | 195 | 4,760 | £458 | -41.0% ▼ |
| Insulin glargine | 192 | 1,142 | £11.9K | -32.4% ▼ |
| Nitrazepam | 191 | 3,374 | £190 | +267.6% ▲ |
| Tapentadol | 191 | 9,548 | £4.1K | +364.0% ▲ |
| Estriol | 191 | 2,923 | £4.0K | -10.2% ▼ |
| Levetiracetam | 189 | 22.8K | £965 | -58.7% ▼ |
| Lidocaine hydrochloride | 187 | 2,692 | £3.9K | +8.4% ▲ |
| Combined ethinylestradiol 30mcg | 183 | 20.0K | £1.1K | -34.1% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 177 | 21.0K | £1.7K | +17.1% ▲ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 176 | 191 | £8.5K | +5.2% ▲ |
| 175 | 595 | £325 | -20.6% ▼ | |
| Eplerenone | 173 | 2,894 | £374 | -34.8% ▼ |
| Lisinopril | 172 | 8,960 | £287 | -84.3% ▼ |
| Bisacodyl | 171 | 10.1K | £509 | +30.5% ▲ |
| Solifenacin | 171 | 5,644 | £207 | -64.2% ▼ |
| Felodipine | 170 | 5,250 | £894 | -71.4% ▼ |
| Diltiazem hydrochloride | 168 | 10.5K | £1.3K | -45.3% ▼ |
| Pizotifen malate | 164 | 5,327 | £229 | +99.0% ▲ |
| Carbomer 940/980 | 164 | 2,010 | £474 | +7.7% ▲ |
| Olanzapine | 160 | 5,656 | £480 | -56.8% ▼ |
| Oxycodone hydrochloride | 159 | 14.6K | £1.6K | -37.9% ▼ |
| Methotrexate | 157 | 3,952 | £237 | -51.8% ▼ |
| Oxybutynin | 155 | 10.2K | £181 | -18.6% ▼ |
| 152 | 15.5K | £684 | +16.0% ▲ | |
| Ispaghula husk | 146 | 6,824 | £1.2K | +10.8% ▲ |
| Semaglutide | 145 | 3,998 | £13.1K | -39.8% ▼ |
| Umeclidinium bromide/vilanterol | 144 | 144 | £4.4K | -26.2% ▼ |
| Irbesartan | 141 | 5,264 | £208 | -42.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.